Free Trial

Karyopharm Therapeutics (KPTI) SEC Filings & 10K Form

Karyopharm Therapeutics logo
$4.95 +0.53 (+11.99%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$4.96 +0.00 (+0.10%)
As of 04/17/2025 04:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Karyopharm Therapeutics SEC Filings

DateFilerForm TypeView
04/14/2025
7:24 AM
Karyopharm Therapeutics (Filer)
Form ARS
04/14/2025
7:15 AM
Karyopharm Therapeutics (Filer)
Form DEF 14A
04/14/2025
7:19 AM
Karyopharm Therapeutics (Filer)
Form DEFA14A
04/10/2025
4:23 PM
Affinity Asset Advisors, LLC (Filed by)
Karyopharm Therapeutics (Subject)
Form SCHEDULE 13G
03/06/2025
3:13 PM
Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:48 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:49 PM
Abate Kristin (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:46 PM
Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
6:32 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
6:36 AM
Karyopharm Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
8:36 AM
Adage Capital Management, L.P. (Filed by)
Karyopharm Therapeutics (Subject)
Form SCHEDULE 13G
02/05/2025
3:16 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:34 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:03 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:07 PM
Karyopharm Therapeutics (Issuer)
Macomber Lori (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
6:08 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
3:35 PM
Karyopharm Therapeutics (Filer)
Form PRE 14A
12/05/2024
3:15 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
6:09 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
2:50 PM
Karyopharm Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/06/2024
3:06 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
7:02 AM
Karyopharm Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/05/2024
6:47 AM
Karyopharm Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
6:41 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
10:49 AM
Karyopharm Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
6:41 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
8:30 AM
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G
09/05/2024
3:28 PM
Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:13 PM
Cheng Sohanya Roshan (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:24 PM
Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:26 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:05 PM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:31 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
6:33 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
6:42 AM
Karyopharm Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
3:14 PM
Karyopharm Therapeutics (Issuer)
Poulton Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:07 PM
Karyopharm Therapeutics (Subject)
Form SC TO-I/A
07/09/2024
3:15 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
3:32 PM
BlackRock Inc. (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G/A
06/20/2024
7:01 AM
Karyopharm Therapeutics (Subject)
Form SC TO-I
06/09/2024
11:15 PM
Karyopharm Therapeutics (Filer)
Form EFFECT
Trump and Musk fight back (Ad)

Is there more to the Musk–Trump relationship than meets the eye? Jeff Brown thinks so — and he believes it has to do with a top-level initiative to build the ultimate military-grade AI system. He’s calling it the “AI Superweapon,” and he says it could soon become the center of global tech dominance. At the core of this initiative? A handful of companies tied to America’s most powerful tech platforms — and investors who act before this goes mainstream may have a rare early edge.

Click here to see why Jeff believes this is the biggest stock story of the year — and which companie
06/07/2024
6:18 PM
Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:51 PM
Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
7:00 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2024
4:32 PM
Karyopharm Therapeutics (Issuer)
Oliger Christy J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
4:19 PM
BOHLIN GAREN G (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
4:25 PM
Greene Barry E (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
4:32 PM
Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
4:32 PM
Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
4:32 PM
Karyopharm Therapeutics (Issuer)
Schor Chen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
4:32 PM
Karyopharm Therapeutics (Issuer)
Su Zhen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
3:44 PM
Karyopharm Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/14/2024
3:06 PM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
3:13 PM
Karyopharm Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
6:47 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
6:52 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:56 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KPTI) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners